510(k) Report

510(k) · Cleared

Cleared

Broncholab

K191550510(k) TraditionalCleared Mar 4, 2020266-day reviewClass II21 CFR 892.1750

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Fluidda, Inc. · JAK System, X-Ray, Tomography, Computed

Cleared on Mar 4, 2020 as substantially equivalent to K083227 (Vida Diagnostics, Inc., 2008) after a 266-day review. Its family tree reaches back 7 generations to 1995.

Decided
Mar 4, 2020
Review
266 days
Class
Class II
Product code
JAK
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K954355 (1995). 11 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 7 generations backK954355 Advantage Windows 3D with Navigator OptionGeneral Electric Co. · 1995
  2. 6 generations backK974715 Advantage 3D XRGE Medical Systems · 1998
  3. 5 generations backK984634 3D-AngioSiemens Medical Corp. · 1999
  4. 4 generations backK011447 IN Space 3DSiemens Medical Solutions USA, Inc. · 2001
  5. 3 generations backK043469 Syngo Inspace 4DSiemens AG Medical Solutions · 2005
  6. 2 generations backK071513 Inspace 4D Software Package with Extended FunctionalitySiemens Medical Solutions · 2007
  7. 1 generation backK083227 Vida Pulmonary Workstation 2 (PW2)Vida Diagnostics, Inc. · 2008
  8. This deviceK191550 BroncholabFluidda, Inc. · 2020
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K954355Advantage Windows 3D with Navigator OptionGeneral Electric Co.1995—
−6K974715Advantage 3D XRGE Medical Systems1998—
−5K9846343D-AngioSiemens Medical Corp.1999—
−4K011447IN Space 3DSiemens Medical Solutions USA, Inc.2001—
−3K043469Syngo Inspace 4DSiemens AG Medical Solutions2005—
−2K071513Inspace 4D Software Package with Extended FunctionalitySiemens Medical Solutions2007—
−1K083227Vida Pulmonary Workstation 2 (PW2)Vida Diagnostics, Inc.2008—
0 (this device)K191550BroncholabFluidda, Inc.2020—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
199820
200010
FIG. 1 — Lineage of K191550, 1995–2020Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JAK? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new JAK device

  1. #1 K230223 iCAC Devicescore 23.5 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K083227Vida Pulmonary Workstation 2 (PW2)
Summary page 4
…Radiology Legally marketed Primary Predicate Device Vida Pulmonary Workstation 2 (PW2), Vida Diagnostics (K083227) Predicate Regulation Number 21 CFR 892.1750 Predicate Classification & Product Code Class II; Product Code…
Vida Diagnostics, Inc.2008—

Also cleared against K083227: 11 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 8 companies; a new generation was cleared every 2.4 years on median.
  • 1 of the 11 ancestors has a recall of any class.
  • 11 other devices also cite its predicate K083227.

How does its category compare?

All JAK devices

JAK System, X-Ray, Tomography, Computed: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · JAK

27in 2025

2007: 142008: 262009: 152010: 72011: 162012: 282013: 172014: 302015: 302016: 252017: 292018: 242019: 282020: 302021: 202022: 302023: 272024: 262025: 272026 (partial year): 21
2007high 30 (2014) · low 7 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JAK

141in 2025

2007: 27 days median2008: 42 days median2009: 31 days median2010: 92 days median2011: 155 days median2012: 121 days median2013: 132 days median2014: 200 days median2015: 140 days median2016: 129 days median2017: 96 days median2018: 114 days median2019: 94 days median2020: 112 days median2021: 145 days median2022: 131 days median2023: 139 days median2024: 141 days median2025: 141 days median2026 (partial year): 167 days median
2007high 200 (2014) · low 27 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JAK

17in 2025

2007: 112008: 162009: 292010: 512011: 342012: 232013: 112014: 102015: 282016: 442017: 332018: 102019: 52020: 82021: 152022: 92023: 92024: 202025: 172026 (partial year): 23
2007high 51 (2010) · low 5 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JAK

219in 2025

2007: 762008: 1202009: 1052010: 1192011: 2052012: 1922013: 4142014: 3082015: 4542016: 3652017: 3382018: 5432019: 2332020: 1772021: 2612022: 1992023: 3102024: 2122025: 219
2007high 543 (2018) · low 76 (2007)2025

MAUDE reports naming product code JAK, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200714271176
2008264216120
2009153129105
201079251119
20111615534205
20122812123192
20131713211414
20143020010308
20153014028454
20162512944365
2017299633338
20182411410543
201928945233
2020301128177
20212014515261
2022301319199
2023271399310
20242614120212
20252714117219
20262116723—

What is it indicated for?

Broncholab provides physicians with reproducible CT values for pulmonary tissue for providing quantitative support for diagnosis and follow-up examination. Broncholab can be used to support physicians in the diagnosis and documentation of pulmonary tissues images (e.g., abnormalities) from CT thoracic datasets. Three-D segmentation and isolation of subcompartments, volumetric analysis, density evaluations, low density cluster analysis, fissure evaluation and reporting tools are combined with a dedicated workflow.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K191550: Broncholab.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K191550

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026